Research
UAB Medicine has a long history of caring for patients with adult congenital heart disease, and the Alabama Adult Congenital Heart Program is the only one in Alabama and one of a handful in the country that provide continuing care for patients as they move into adulthood.
A program that supports historically disadvantaged health professionals chooses two researchers in the UAB Department of Medicine as finalists.

A fatty acid-derived bioactive molecule called lipoxin improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response.

UAB’s REGARDS study finds that disparities exist within men and older patients’ being prescribed stroke-preventing medication in the southeastern United States.
Anezi Uzendu, M.D., has touched the hearts of many patients and colleagues in his time at UAB; but now that reach is bigger than ever, after his own heart failed him.
Authors conclude that the relationship between the complexity of left main coronary artery disease and clinical outcomes varies over time and lay out approaches for individualized strategy of revascularization.
A UAB symposium on cardiovascular tissue engineering brought together some of the best in the business in this rapidly developing field of translational medicine.
Knowledge from this study and others may help physicians boost healing and prevent heart failure in patients after a heart attack.
The husband and wife duo serve as faculty in the UAB Division of Cardiovascular Disease.
The grant will initially fund two fellowship positions for postdoctoral fellows (basic or clinical) wishing to train in the area of heart failure research.
A heart attack can happen even if to those who are relatively young and fit, and genetics can play a role.
UAB has named James Davies the director of the Division of Cardiothoracic Surgery.
Diagnosing and treating women who might otherwise slide under the radar is the goal of UAB Medicine’s quickly growing Women’s Heart Health Clinic, which officially opened in 2017.
The findings suggest targeting specific T-cell subsets may be a therapeutic approach to prevent heart failure after a heart attack.
Some people inherit a condition that elevates their cholesterol to an excessive degree, and no amount of diet or exercise can bring the numbers down. UAB researchers are developing and testing a new peptide that may lead to better treatment options.
According to the National Heart, Lung and Blood Institute, 23 percent of women will die within one year after having a heart attack , and nearly 46 percent of women become disabled with heart failure.
James Ward could not walk from his office to his car without having trouble breathing until a life-changing heart pump gave him hope.
Massoud Leesar, M.D., performed the first procedure Jan. 25, 2017, and that is good news for people who suffer strokes as a result of patent foramen ovale, or PFO.
According to the American Heart Association, heart disease is the leading global cause of death. These foods can promote cardiovascular health.
The UAB study, an updated meta-analysis of the use of implantable cardioverter-defibrillators for non-ischemic cardiomyopathy, provides further support to the current American Heart Association and American College of Cardiology guidelines and challenges the recently published DANISH trial.
Page 2 of 5
Back to Top